These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
347 related items for PubMed ID: 20387494
1. [Evaluation of combined determinations of Epstein-Barr virus antibodies for nasopharyngeal carcinoma assessed with receiver operating characteristic curve based on logistic regression]. Cai YL, Zheng YM, Cheng JR, Li J, Mo YK, Zhong QY. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Oct; 23(5):384-7. PubMed ID: 20387494 [Abstract] [Full Text] [Related]
2. [Evaluation of detection of Epstein-Barr virus Rta/IgG in nasopharyngeal carcinoma]. Zheng YM, Cain YL, Cheng JR, Li J, Mo YK, Gao JQ, Dong ZR, Zhong QY. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Aug; 23(4):285-7. PubMed ID: 20108775 [Abstract] [Full Text] [Related]
3. [Combined detection of Epstein-Barr virus antibodies for serodiagnosis of nasopharyngeal carcinoma]. Cai YL, Zheng YM, Wang W, Wei Y, Shen XX, Cheng JR, Wu YS, Gao JQ, Zhong WM, Li J. Nan Fang Yi Ke Da Xue Xue Bao; 2010 Dec; 30(12):2746-8. PubMed ID: 21177196 [Abstract] [Full Text] [Related]
4. Diagnostic significance of combined detection of Epstein-Barr virus antibodies, VCA/IgA, EA/IgA, Rta/IgG and EBNA1/IgA for nasopharyngeal carcinoma. Cai YL, Li J, Lu AY, Zheng YM, Zhong WM, Wang W, Gao JQ, Zeng H, Cheng JR, Tang MZ. Asian Pac J Cancer Prev; 2014 Dec; 15(5):2001-6. PubMed ID: 24716925 [Abstract] [Full Text] [Related]
5. Analyses of the prognostic significance of the Epstein-Barr virus transactivator ZEBRA protein and diagnostic value of its two synthetic peptides in nasopharyngeal carcinoma. Dardari R, Menezes J, Drouet E, Joab I, Benider A, Bakkali H, Kanouni L, Jouhadi H, Benjaafar N, El Gueddari B, Hassar M, Khyatti M. J Clin Virol; 2008 Feb; 41(2):96-103. PubMed ID: 18024156 [Abstract] [Full Text] [Related]
6. Complementary serum test of antibodies to Epstein-Barr virus nuclear antigen-1 and early antigen: a possible alternative for primary screening of nasopharyngeal carcinoma. Chang KP, Hsu CL, Chang YL, Tsang NM, Chen CK, Lee TJ, Tsao KC, Huang CG, Chang YS, Yu JS, Hao SP. Oral Oncol; 2008 Aug; 44(8):784-92. PubMed ID: 18206420 [Abstract] [Full Text] [Related]
7. Expression of EBV antibody EA-IgA, Rta-IgG and VCA-IgA and SA in serum and the implication of combined assay in nasopharyngeal carcinoma diagnosis. Xia C, Zhu K, Zheng G. Int J Clin Exp Pathol; 2015 Aug; 8(12):16104-10. PubMed ID: 26884888 [Abstract] [Full Text] [Related]
9. Establishment of VCA and EBNA1 IgA-based combination by enzyme-linked immunosorbent assay as preferred screening method for nasopharyngeal carcinoma: a two-stage design with a preliminary performance study and a mass screening in southern China. Liu Y, Huang Q, Liu W, Liu Q, Jia W, Chang E, Chen F, Liu Z, Guo X, Mo H, Chen J, Rao D, Ye W, Cao S, Hong M. Int J Cancer; 2012 Jul 15; 131(2):406-16. PubMed ID: 21866545 [Abstract] [Full Text] [Related]
10. Evaluation of commercial EBV RecombLine assay for diagnosis of nasopharyngeal carcinoma. Paramita DK, Fachiroh J, Haryana SM, Middeldorp JM. J Clin Virol; 2008 Aug 15; 42(4):343-52. PubMed ID: 18455473 [Abstract] [Full Text] [Related]
11. Application of logistic regression in combination with multiple diagnostic tests for auxiliary diagnosis of nasopharyngeal carcinoma. Jiang SQ, Liu Q. Ai Zheng; 2009 Feb 15; 28(2):177-80. PubMed ID: 19550133 [Abstract] [Full Text] [Related]
12. Evaluation of Epstein-Barr virus antigen-based immunoassays for serological diagnosis of nasopharyngeal carcinoma. Tang JW, Rohwäder E, Chu IM, Tsang RK, Steinhagen K, Yeung AC, To KF, Chan PK. J Clin Virol; 2007 Dec 15; 40(4):284-8. PubMed ID: 17977062 [Abstract] [Full Text] [Related]
13. Single-assay combination of Epstein-Barr Virus (EBV) EBNA1- and viral capsid antigen-p18-derived synthetic peptides for measuring anti-EBV immunoglobulin G (IgG) and IgA antibody levels in sera from nasopharyngeal carcinoma patients: options for field screening. Fachiroh J, Paramita DK, Hariwiyanto B, Harijadi A, Dahlia HL, Indrasari SR, Kusumo H, Zeng YS, Schouten T, Mubarika S, Middeldorp JM. J Clin Microbiol; 2006 Apr 15; 44(4):1459-67. PubMed ID: 16597877 [Abstract] [Full Text] [Related]
14. [Relationship between clinical stages of nasopharyngeal carcinoma and Epstein-Barr virus antibodies Rta/IgG, EBNA1/IgA, VCA/IgA and EA/IgA]. Cai YL, Zheng YM, Cheng JR, Wang W, Zhang YN, Wang WH, Wu YS, Zhong WM, Li J, Mo YK. Nan Fang Yi Ke Da Xue Xue Bao; 2010 Mar 15; 30(3):509-11. PubMed ID: 20335122 [Abstract] [Full Text] [Related]
16. Enhancing the efficiency of Epstein-Barr viral serologic test in the diagnosis of nasopharyngeal carcinoma. Zhang C, Zong Y, Huang B, Sun Y, Ye Y, Feng K, Li J, Zhang F. Zhonghua Zhong Liu Za Zhi; 2002 Jul 15; 24(4):356-9. PubMed ID: 12408763 [Abstract] [Full Text] [Related]
17. Comparison of three different serological techniques for primary diagnosis and monitoring of nasopharyngeal carcinoma in two age groups from Tunisia. Karray H, Ayadi W, Fki L, Hammami A, Daoud J, Drira MM, Frikha M, Jlidi R, Middeldorp JM. J Med Virol; 2005 Apr 15; 75(4):593-602. PubMed ID: 15714486 [Abstract] [Full Text] [Related]
19. Native early antigen of Epstein-Barr virus, a promising antigen for diagnosis of nasopharyngeal carcinoma. Paramita DK, Fachiroh J, Artama WT, van Benthem E, Haryana SM, Middeldorp JM. J Med Virol; 2007 Nov 15; 79(11):1710-21. PubMed ID: 17854043 [Abstract] [Full Text] [Related]